Recent studies have found that silencing AHR promotes apoptosis in chronic lymphocytic leukemia (CLL) cells and synergistically enhances the cytotoxicity of the chemotherapy drug venetoclax [18]. This evidence concerns the gene AHR and B-cell chronic lymphocytic leukemia.